BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, February 11, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 10, 2001
View Archived Issues
Incara's porphyrin-based catalytic antioxidant is neuroprotective in ischemia
Read More
Dual PPAR agonist shows good preclinical results
Read More
Companies form strategic agreement to develop asthma and allergic rhinitis products
Read More
Preliminary animal studies indicate that Oxycyte may be safer than other PFC emulsions
Read More
Final results of PH-10 pilot study in the treatment of plaque psoriasis reported
Read More
Theratechnologies submits IND application to Health Canada for ThGRF1-44
Read More
Osteoarthritis product launched in Europe
Read More
Biora enters distribution agreement with USBiomaterials for new periodontal disease product
Read More
New selective dopamine D4 complete antagonist reported
Read More
Genetically modified neural stem cells may be useful in the treatment of PD
Read More
Avanir acquires technology to develop MIF modulators
Read More
Roche receives first approval for PEGASYS
Read More
Schering AG acquires rights to fasudil in the U.S. and Europe
Read More
Antalarmin inhibits stress-induced gastric ulceration in rats
Read More
New cathepsin and calpain inhibitors and their use described by Senju
Read More
Urokinase inhibitors with antiangiogenic activity reported by Abbott
Read More
Kyoto Pharmaceutical reports new derivatives with glucose- and triglyceride-lowering activity
Read More
Novel thrombin inhibitors presented by Akzo Nobel
Read More
Sumitomo describes new compounds for the treatment of inflammation and autoimmune diseases
Read More
